Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Gross Margin (2021 - 2025)

Pulse Biosciences has reported Gross Margin over the past 3 years, most recently at 224.42% for Q3 2025.

  • Quarterly results put Gross Margin at 224.42% for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was 224.42% (changed N/A YoY), and the annual figure for FY2022 was 1606.29%, down 156571.0%.
  • Gross Margin for Q3 2025 was 224.42% at Pulse Biosciences, up from 348.0% in the prior quarter.
  • Over the last five years, Gross Margin for PLSE hit a ceiling of 26.66% in Q3 2021 and a floor of 348.0% in Q2 2022.
  • Median Gross Margin over the past 3 years was 127.25% (2022), compared with a mean of 155.31%.